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ies but that failed to protect against disease unless very high
titers were achieved (29, 46, 47, 59, 62). In addition, injection
of fish with purified E. ictaluri lipopolysaccharide did not provide protective immunity against ESC unless Freund’s complete adjuvant was used, despite the development of high antibody titers in all lipopolysaccharide-injected fish (50). These
data, combined with the suggested intracellular nature of E.
ictaluri (4, 37, 39), all indicate that stimulation of a strong CMI
response is required for effective vaccination against ESC.
Injection of killed preparations in combination with adjuvants is one way to stimulate increased CMI, but because of the
large numbers, small size, and low economic value of individual fish, this route of vaccination is not practical for use by
commercial catfish producers. Live attenuated strains of facultative, intracellular bacterial pathogens that maintain the
ability to invade host tissues by natural routes should also
generate strong CMI. Because virulent strains of E. ictaluri are
invasive in channel catfish via oral and immersion routes of
exposure (4, 40, 53), a live attenuated strain of E. ictaluri that
invades and temporarily persists in catfish tissues when delivered by either of these two routes should effectively stimulate
a CMI response.
Certain auxotrophic phenotypes of bacterial pathogens are
consistently attenuated because of the limited availability of a
required nutrient(s) in vertebrate tissues, making them suitable for use as live vaccines (13, 56). The best known of these
are the aro mutants, which are effective as live vaccines for
several bacterial species (7, 20, 21, 30, 49, 55). A thymineauxotrophic strain of Shigella flexneri is also effective as a live
vaccine (1). Purine auxotrophs are consistently attenuated in
mammalian hosts as well (3, 5, 8, 14, 19, 23, 28), especially
when they have a specific requirement for adenine (34). In
mammalian hosts, however, adenine-auxotrophic Salmonella
purA mutants are less effective as vaccines than aroA mutants
(42, 54), possibly because purA mutants are overly attenuated
by the extremely low availability of adenine in mammalian

The largest aquaculture industry in the United States is the
channel catfish industry, and the most serious disease affecting
this industry is enteric septicemia of catfish (ESC) (32, 36). The
causative agent, Edwardsiella ictaluri, was first described by
Hawke in 1979 after it was isolated from catfish farms in
Georgia and Alabama (15). It has since been reported in every
state that produces channel catfish (61). A recent summary of
catfish diagnostic cases for the years 1991 to 1995 in the southeastern United States indicates that 3,651 of 12,723 cases, or
28.7%, had E. ictaluri as the primary etiology (36).
E. ictaluri strains are serologically and biochemically homogeneous (6, 43, 44, 63). As a result, numerous researchers have
evaluated killed bacterins for protection against ESC (29, 45–
47, 50, 60, 62), with equivocal results. Many reported successes
are difficult to evaluate due to a failure to control natural
exposure to E. ictaluri in many of the studies, resulting in
positive antibody titers in nonvaccinated fish. A protective response was suggested in field trials using a killed preparation,
but Thune et al. (60) suggested that subclinical exposure of
vaccinated fish to E. ictaluri during periods in which temperatures were not conducive to disease was important in establishing the response.
Vaccination of laboratory-reared, specific-pathogen-free
(SPF) fish by immersion and oral methods induced an antibody
response in vaccinated fish, but little or no protection from
disease (59), indicating that cell-mediated immunity (CMI) is
important in developing protective immunity to ESC. This
hypothesis is supported by several studies using a variety of
antigen preparations that were effective in stimulating antibod* Corresponding author. Mailing address: Department of Veterinary Microbiology and Parasitology, School of Veterinary Medicine,
Louisiana State University, Baton Rouge, LA 70803. Phone: (504)
346-3308. Fax: (504) 346-5715. E-mail: thune@vt8200.vetmed.lsu.edu.
† Manuscript no. 97-64-0165 from the Louisiana Agricultural Experiment Station.
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In this study, an adenine-auxotrophic strain of Edwardsiella ictaluri was constructed and its virulence, tissue
persistence, and vaccine efficacy were evaluated. A clone containing the purA gene was isolated from an E.
ictaluri genomic library, sequenced, and shown to have an overall sequence identity of 79.3% at the nucleotide
level and 85.7% at the amino acid level with the Escherichia coli purA gene. The cloned E. ictaluri purA gene was
mutated by deleting a 598-bp segment of the gene and inserting the kanamycin resistance gene from Tn903 into
the gap. The DpurA::Kmr gene was subcloned into the suicide plasmid pGP704, and the resulting plasmid was
used to deliver the modified gene into a virulent strain of E. ictaluri by conjugation. Homologous recombination
replaced the chromosomal purA gene with the mutated gene to create an adenine-auxotrophic strain (LSU-E2).
Compared to wild-type E. ictaluri, LSU-E2 was highly attenuated by the injection, immersion, and oral routes
of exposure. By the injection route, LSU-E2 had a 50% lethal dose (LD50) that was greater than 5 logs10 higher
than the LD50 for wild-type E. ictaluri. In a tissue persistence study, LSU-E2 was able to invade channel catfish
by the immersion route and persist in internal organs for at least 48 h. Channel catfish that were vaccinated
with a single immersion dose of LSU-E2 had mortality significantly lower (P < 0.01) following a wild-type E.
ictaluri challenge than that of nonvaccinated fish.
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TABLE 1. Bacterial strains and plasmids

Escherichia coli
CC118 lpir
SM10 lpir
Edwardsiella ictaluri
93-146
LSU-E2
Plasmids
pEIl1
pEIl4
pEIl5
pNK2859
pEIl6
pGP704
pEIl7

Description

Source or reference

D(ara-leu) araD DlacX74 galE galK phoA20 thi-1 rpsE rpoB argE(Am)
recA lpir phage lysogen
Kmr thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu lpir phage lysogen

10

Wild-type E. ictaluri isolated in 1993 from moribund channel catfish in a
natural outbreak of ESC on a commercial farm
As for 93-146 except DpurA::Tn903 (Kmr)

Louisiana State University Aquatic
Animal Diagnostic Laboratory
This study

Apr, pBluescript derivative with 1,104-bp E. ictaluri purA PCR product
inserted in EcoRV site
Kmr, pBK-CMV derivative with 5.6-kb segment of the E. ictaluri
chromosome containing the purA gene inserted in BamHI site
Apr, pBluescript derivative with 3.5-kb NotI fragment containing the
purA gene
Apr Kmr, derivative of pBR322 with mini-Tn10Km (Tn903 Km), PtacP
Apr Kmr, pEIl5 derivative with 598-bp NarI deletion in the purA gene
and 1.7-kb BamHI segment of Tn903 inserted in NarI deletion site
Apr, pBR322 derivative with R6K ori, mob RP4, polylinker from M13
tg131
Apr, Kmr, pGP704 derivative with 4.6-kb NotI fragment containing
modified E. ictaluri purA gene inserted in EcoRV site

This study

tissues (34). Although direct measurements of adenine availability in fish tissues are not available, it is known that certain
aspects of purine metabolism in fish differ from those in mammals (17, 31, 38, 65). These metabolic differences may result in
increased adenine availability in fish tissues compared to mammalian tissues, which could make adenine auxotrophs more
effective as live attenuated bacterial vaccines in fish than they
are in mammals. Consequently, this study was undertaken to
produce an adenine-auxotrophic strain of E. ictaluri and evaluate its invasiveness, infectivity, and ability to protect channel
catfish from ESC.
MATERIALS AND METHODS
Bacterial media and antibiotics. Bacterial strains, plasmids, and their sources
are listed in Table 1. Escherichia coli was grown at 37°C with Luria-Bertani (LB)
broth and agar plates (51). E. ictaluri was grown at 28°C with brain heart infusion
(BHI) broth and agar plates or with Trypticase soy agar (TSA) II plates with 5%
sheep blood (BA). lZap Express bacteriophage (Stratagene, La Jolla, Calif.)
were grown in E. coli XL1-Blue MRF9 (Stratagene) with NZYM agar plates and
NZYM top agarose (51). E. ictaluri defined minimal medium (EIMM) broth and
agar plates (9) with and without supplemental adenine (25 mg/ml) were used for
nutritional characterization of E. ictaluri strains. The API 20E system (bioMérieux Vitek, Hazelwood, Mo.) was used for species identification and biochemical characterization of E. ictaluri strains. Conjugates between E. ictaluri
and E. coli were grown at 28°C on LB plates.
The F9 episome was maintained in E. coli XL1-Blue MRF9 with tetracycline
selection at 12.5 mg/ml. Ampicillin at 200 mg/ml was used to maintain pBluescript
(Stratagene), pGP704, and their derivatives. Kanamycin at 50 mg/ml was used to
maintain plasmids derived from the pBK-CMV phagemid and plasmids carrying
Tn903. Colistin at 10 mg/ml was used for counterselection against E. coli SM10
lpir following conjugations. For blue-white screening of DNA cloned into pBluescript, E. coli XL1-Blue MRF9 was spread on LB plates with 100 ml of 100 mM
IPTG (isopropyl-b-D-thiogalactopyranoside) and 40 ml of 2% X-Gal (5-bromo4-chloro-3-indolyl-b-D-galactopyranoside).
DNA preparations and manipulations. E. ictaluri genomic DNA was prepared
from 100-ml overnight cultures by a modification of the protocol of Ausubel et
al. (2). Small- and large-scale preparations of plasmid DNA were made by
alkaline lysis (51), and large-scale plasmid preparations were purified with Qiagen-tip 100 columns (Qiagen, Chatsworth, Calif.). Restriction endonucleases,
DNA polymerase I Klenow fragment, calf intestinal alkaline phosphatase, and
T4 DNA ligase were obtained from New England Biolabs (Beverly, Mass.) and
used according to the manufacturer’s protocols. DNA fragments were purified
from agarose gels with the Elu-Quick DNA Purification Kit (Schleicher &
Schuell, Keene, N.H.).
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This study
This study
25
This study
35
This study

Electroporation. Both E. coli and E. ictaluri were prepared for electroporation
by the protocol of Ausubel et al. (2). Washed E. coli cells were transfected by
electroporation in 0.2-cm cuvettes at 2.5 kV and 25 mF with the pulse controller
set at 200 V, and washed E. ictaluri cells were electroporated by the same
protocol at 1.75 kV. Bacteria were recovered for 1 h in BHI broth at 37°C (E.
coli) or 28°C (E. ictaluri) before being spread on selective medium.
Amplification of a portion of the E. ictaluri purA gene. An 1,104-bp fragment
of the E. ictaluri purA gene was amplified from genomic E. ictaluri DNA by PCR
with primers derived from conserved regions of the E. coli purA gene based on
alignments of published purA gene sequences (26, 33, 64). All PCRs were conducted on a Perkin-Elmer (Foster City, Calif.) DNA Thermal Cycler 480 with
AmpliTaq DNA polymerase at pH 8.5 with a magnesium concentration of 1.5
mM and with 125 ng of template DNA per reaction mixture and at concentrations of 0.25 mM for each primer and 30 mM for each deoxynucleoside triphosphate. Cycle conditions were at 95°C for 30 s, 53°C for 45 s, and 72°C for 45 s for
35 cycles, with an initial denaturation step at 95°C for 2 min and a final extension
step at 72°C for 10 min. To increase PCR product yield, a second PCR was
carried out with the product from the first PCR as the template (0.5 ml of a 1/10
dilution) under the same conditions. Prior to ligation into pBluescript, the purA
PCR product was purified with the Elu-Quick DNA Purification Kit to remove
excess primers and deoxynucleoside triphosphates. Primers for both PCR and
sequencing were synthesized by solid-phase cyanoethyl phosphoramidite chemistry on a Perkin-Elmer/Applied Biosystems (ABI) DNA Synthesizer Model 394.
DNA hybridization. Agarose gels were prepared for Southern hybridization by
the protocol of Ausubel et al. (2), and DNA was transferred to Nytran Plus
0.45-mm-pore-size nylon membranes (Schleicher & Schuell) with the PosiBlot
30-30 pressure blotter and pressure control station (Stratagene, Inc.). The
1,104-bp E. ictaluri purA PCR fragment was labeled with the ECL direct nucleic
acid labeling and detection system (Amersham Life Sciences, Arlington Heights,
Ill.) and used as a probe for both plaque and Southern hybridizations. Prehybridization, hybridization, and stringency washes were all performed in tubes at
41°C according to the ECL protocol with a hybridization oven with an integral
rotisserie device, followed by chemiluminescent detection.
Library screening. An E. ictaluri genomic library was constructed by cloning E.
ictaluri genomic DNA that had been partially digested with Sau3AI into the
BamHI site of lZap Express (Stratagene, Inc.). E. coli XL1-Blue MRF9 was
infected with the library according to the lZap Express protocol and spread on
three plates containing approximately 11,000 PFU per plate. Plaques were transferred to Nytran Plus 0.45-mm-pore-size nylon membranes and screened with the
labeled 1,104-bp probe. One positive plaque was purified, excised as a phagemid
in E. coli XLOLR according to the Stratagene protocol, and confirmed to
contain the purA gene in its insert by Southern hybridization.
DNA sequencing. The cloned 1,104-bp purA PCR fragment (carried on plasmid pEI11) was sequenced on both strands by the dideoxynucleotide chain
termination method (52) with Taquence Version 2.0 (United States Biochemical,
Cleveland, Ohio). The complete sequence of the remainder of the purA gene and
flanking chromosomal sequence (carried on plasmid pEIl4) was determined with
the ABI Prism Dye Terminator Cycle Sequencing Ready Reaction Kit and an
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ABI Prism 310 Genetic Analyzer according to the manufacturer’s directions
(Perkin-Elmer). The ABI Prism Dye Terminator Cycle Sequencing Ready Reaction Kit was also used to sequence PCR products amplified from E. ictaluri
LSU-E2 genomic DNA. Generated sequences were assembled, analyzed, and
aligned with other sequences with the Wisconsin Sequence Analysis Package
Version 8.0 (Genetics Computer Group, Madison, Wis.) and PC/Gene (IntelliGenetics, Mountain View, Calif.).
Bacterial conjugation. Conjugation was conducted between E. coli SM10 lpir
and E. ictaluri 93-146 by a modification of the protocol of de Lorenzo and
Timmis (10) in which the two bacteria were mixed in 5 ml of 10 mM MgSO4 in
a 2:1 ratio (approximately 1.3 3 108 E. ictaluri cells and 6.5 3 107 E. coli cells),
collected on a Gelman 0.45 mM Metricel filter, and incubated overnight at 28°C
on LB agar plates. Bacteria were resuspended in 5 ml of 10 mM MgSO4, and
mutant E. ictaluri colonies were selected by spreading 100-ml aliquots of the
suspension on LB-kanamycin-colistin plates. Two hundred fifty kanamycin-resistant colonies were screened for ampicillin sensitivity by patching colonies onto
LB-ampicillin-kanamycin plates.
Phenotypic stability of LSU-E2 in nonselective media. The stability of the
adenine-auxotrophic phenotype in E. ictaluri LSU-E2 was confirmed by passing
the mutant through 30 overnight 5-ml BHI broth cultures. The final two 5-ml
cultures were pelleted by centrifugation in a swinging bucket rotor at 4,750 3 g
for 10 min, resuspended in 0.9 ml of sterile 0.9% saline, spread on EIMM plates,
and checked for growth after 4 days. Totals of E. ictaluri cells screened were
determined by dilution plate counts.
Genotypic confirmation of LSU-E2. The LSU-E2 DpurA::Kmr construction
was confirmed in a series of PCRs with genomic DNA from LSU-E2 and E.
ictaluri 93-146 as templates. Plasmid pEIl7 DNA was used as a positive control
for the reactions. Primer pairs included 903Kan1 and 903Kan2, specific for the
Tn903 sequence; pBRAmp1 and pBRAmp2, specific for the ampicillin resistance gene sequence; PurAU1, specific for the E. ictaluri purA gene sequence,
and 903Kan1; and PurAM11, specific for the E. ictaluri purA gene sequence, and
Tn903M2, specific for the Tn903 sequence. The PurAU1/903Kan1 PCR product
and the PurAM11/Tn903M2 PCR product amplified from LSU-E2 DNA were
both sequenced to confirm their identities.
SPF channel catfish. Egg masses were obtained from commercial channel
catfish producers with no history of ESC outbreaks, disinfected with 100 ppm of
free iodine, and hatched in closed recirculating systems in an SPF laboratory.
Fish were maintained in the SPF laboratory through either the fingerling or the
juvenile stage. Prior to experimental infection, SPF fish were restocked into
20-liter tanks in separate challenge laboratories and acclimated for 2 to 4 weeks.
Flow rates in the challenge tanks were maintained at approximately 300 to 400
ml per min with dechlorinated municipal water, and temperatures were maintained at 25 6 1°C.
Attenuation trial. Six hundred SPF channel catfish fingerlings, weighing approximately 5 g each, were stocked at a rate of 10 per tank, and three tanks were
randomly assigned to each of 20 treatment groups. Treatment groups were
experimentally infected with a specified dose of wild-type E. ictaluri or LSU-E2
E. ictaluri by one of three routes: immersion, injection, or oral administration.
For the immersion challenge, the specified dose of either 93-146 wild-type or
LSU-E2 bacterial culture was added directly to the tanks. For the wild type, two
doses were used: a low dose of approximately 6.5 3 106 CFU/ml and a high dose
of approximately 6.5 3 107 CFU/ml. Two doses were also used for LSU-E2:
approximately 1.6 3 106 CFU/ml and 1.6 3 107 CFU/ml. Negative control
treatment tanks were exposed to 200 ml of BHI broth. For the injection, challenge fish were anesthetized with 100 mg of tricaine methanesulfonate (MS-222)
per liter and given intraperitoneal injections of 0.1 ml of the specified dose of
93-146 wild type or LSU-E2. Five treatment groups were injected with wild-type
E. ictaluri at doses corresponding to approximately 1.3 3 102 to 1.3 3 106
CFU/fish, and four treatment groups were injected with LSU-E2 at doses corresponding to 1.6 3 105 to 1.6 3 108 CFU/fish. Negative control fish were each
injected with 0.1 ml of BHI broth. Orally challenged fish were also anesthetized
with MS-222, and a straight 1.5-in 22-gauge oral feeding tube was passed into the
stomach of each fish to deliver 0.1 ml of the specified dose of 93-146 wild type or
LSU-E2. Two treatment groups were infused with wild-type E. ictaluri at doses
corresponding to approximately 1.3 3 108 and 1.3 3 109 CFU/fish, and two
treatment groups were infused with LSU-E2 at doses corresponding to approximately 1.6 3 107 and 1.6 3 108 CFU/fish. Negative control fish were each
infused with 0.1 ml of BHI broth.
Mortality was recorded for each 24-h period after experimental infection until
three consecutive days passed without mortality. A sample of trunk kidney from
each dead fish was streaked on BA to confirm E. ictaluri as the cause of death.
Samples from fish exposed to wild-type E. ictaluri were cultured on BA, and
samples from fish exposed to LSU-E2 E. ictaluri were cultured on both BHI
plates and BA. For the injection challenge, a 50% lethal dose (LD50) was
calculated for wild-type and mutant E. ictaluri by the method of Reed and
Muench (48).
Tissue distribution and persistence. Sixty SPF channel catfish fingerlings were
stocked at a rate of 10 per tank and randomly divided into two treatment groups
with three tanks per treatment. One of the treatment groups was experimentally
infected with wild-type E. ictaluri, and the other was experimentally infected with
LSU-E2. Both experimental infections were by immersion exposure. Wild-type
E. ictaluri or LSU-E2 bacterial culture was added directly to the flowthrough
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tanks at doses corresponding to approximately 3.5 3 107 CFU/ml for wild type
and 6.7 3 106 CFU/ml for LSU-E2. Water flow was stopped for 15 min following
initial exposure and then resumed.
At 2, 6, 12, 24, 48, and 72 h postexposure, one fish was removed from each tank
and euthanized by transfer to water containing 1 g of MS-222 per liter. In the
wild-type treatment, the study was extended and fish were also collected at 96
and 120 h, although only two fish were sampled at 120 h. One fish was collected
from each tank prior to experimental infections for a 0-h sample. By aseptic
technique, samples were taken of liver, spleen, head kidney, and trunk kidney
from each fish, suspended in 0.5 ml of sterile 0.9% saline solution, weighed, and
pulverized. The resulting suspension was serially diluted in 0.9% saline solution
in triplicate with 96-well plates, and 20-ml aliquots were dropped onto BHI plates
for quantification. Colonies were counted after incubation for 48 h. E. ictaluri
and other bacterial species were identified with the API 20E system.
The averages of the 3 log10-transformed bacterial concentrations for each
tissue at each time were compared with SAS Version 6 (SAS Institute, Cary,
N.C.) analysis of variance in the general linear models procedure. Tukey’s studentized range test (per SAS program manual) was used for main effects, and the
least-squares means Bonferroni adjusted t test was used for interaction effects.
Vaccine trial. One hundred eighty juvenile SPF channel catfish were stocked
at a rate of 15 per tank and randomly divided into two treatment groups with six
tanks per treatment. One treatment group was vaccinated with LSU-E2 E.
ictaluri by immersion, and the other group was not vaccinated. Two hundred
milliliters of an LSU-E2 overnight culture was added directly to the tanks designated for vaccinated fish, and water flow was stopped for 15 min following
initial exposure. Bacterial concentration in the water was approximately 3.65 3
107 CFU/ml.
On day 27 postvaccination, both vaccinated and nonvaccinated treatment tank
fish were experimentally infected with wild-type E. ictaluri by immersion exposure. E. ictaluri bacterial culture was added directly to the flowthrough tanks for
a final bacterial concentration of approximately 5.3 3 107 CFU/liter in the water.
Water flow was stopped for 15 min following initial exposure and then resumed.
Mortality was recorded for each 24-h period after experimental infection until
day 26 postexposure. Bacterial cultures were taken from the trunk kidney of each
dead fish and cultured on BA to confirm E. ictaluri as the cause of death.
Cumulative daily percent mortality data for each tank was subjected to arcsine
transformation, and each day’s mean transformed percent mortality for vaccinated tanks was compared with each day’s mean for nonvaccinated tanks by
repeated-measures analysis with SAS Version 6 analysis of variance in a split-plot
arrangement of treatments with treatment and tank on the main plot and time on
the subplot.
Nucleotide sequence. The nucleotide sequence for the 1,544-bp purA operon
containing the 1,299-bp E. ictaluri purA gene will appear in the EMBL/GenBank/
DDBJ nucleotide sequence databases under accession no. AF026490.

RESULTS
PCR amplification and gene cloning. Primers based on conserved regions of the E. coli purA gene successfully amplified
an 1,104-bp fragment of the E. ictaluri purA gene, which was
cloned into pBluescript and sequenced to confirmed that a
portion of the E. ictaluri purA gene had been amplified. The E.
ictaluri purA PCR product had 79.1% identity with the E. coli
purA gene. Screening of the E. ictaluri genomic library with the
labeled PCR product yielded plasmid pEIl4. Restriction analysis and Southern hybridization with the labeled E. ictaluri
purA PCR fragment as a probe confirmed that pEIl4 carried
the E. ictaluri purA gene in its insert.
Sequencing results. Table 2 shows a comparison of the E.
ictaluri purA gene sequence and its deduced amino acid sequence with known bacterial purA gene sequences. The E.
ictaluri purA gene has high GC content (59.1%), which reflects
the overall high GC content in the E. ictaluri chromosome (53
mol%) (16). The lengths of the E. ictaluri, E. coli, and Haemophilus influenzae purA genes are all identical at 1,299 bp,
and most of the other genes are within 9 bp of this length.
The highest identity at the nucleotide and amino acid levels
is with E. coli, at 79.3 and 85.7%, respectively. Amino acid
similarity with E. coli is also very high, at 91.9%. Vibrio parahaemolyticus and H. influenzae also had high identity with E.
ictaluri at the nucleotide and amino acid levels, with amino acid
similarity comparable to that of E. coli. Identity is not as high
with the other gram-negative bacteria or with Bacillus subtilis
and Spiroplasma citri, but all had amino acid similarity with E.
ictaluri that was .60%.
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TABLE 2. Comparison of the E. ictaluri purA gene with the purA genes from other bacterial species
Bacterial sp.

Gene length
(bp)

GC content
(%)

Nucleic acid
identitya

Amino acid
identitya

Amino acid
similaritya

Source or
reference

Edwardsiella ictaluri
Escherichia coli
Vibrio parahaemolyticus
Haemophilus influenzae
Thiobacillus ferrooxidans
Brucella abortus
Bacillus subtilis
Spiroplasma citri

1,299
1,299
1,317
1,299
1,290
1,206
1,293
1,308

59.1
53.8
46.0
41.3
59.5
60.6
47.1
30.9

79.3
69.4
65.5
58.9
57.9
52.6
45.2

85.7
75.5
73.7
59.1
50.9
44.9
39.0

91.9
88.2
88.0
76.3
68.3
64.7
61.0

This study
64
33a
57a
26
GenBankb
33
GenBankc

b
c

Percent identities and similarities based on comparison to the E. ictaluri purA gene.
GenBank accession no. L43054.
GenBank accession no. L22971.

The E. coli purA operon has been characterized elsewhere
(64), and the E. ictaluri purA operon appears to have similar
features (Fig. 1). As in E. coli, the E. ictaluri purA gene appears
to be in a monocistronic operon. The promoter sequence for
initiation of transcription for the E. coli purA gene was identified as CTGTAA-(17 bp)-TAGAAT-(7 or 8 bp)-RNA start.
The 210 and 235 regions upstream of the E. ictaluri purA gene
are very similar to those of E. coli, with CTGAAA-(17 bp)TAGAAT located in the same position relative to the start
codon. Both align well with the consensus promoter sequence
for transcription in E. coli, which is TTGACA-(17 bp)TATAAT-(5 to 9 bp)-RNA start (22). In addition, a 6-bp
sequence (GGTGAA) that is similar to the E. coli purA ShineDalgarno sequence (GGTGAT) is present 8 bp upstream of
the start codon in E. ictaluri. E. coli has two regions downstream of its stop codon that have the potential to form hairpin
loops, and the second of these has the features of a r-independent terminator. E. ictaluri has a 13-bp-long inverted repeat
beginning 17 bp downstream of the stop codon that also has
features that suggest that it is capable of r-independent termination, including a region of GC-rich split dyad symmetry
followed by a string of T residues. The presence of this terminator is a good indication that the purA mRNA transcript
contains no downstream genes.
Initiation of the purA transcript in E. coli is under the control
of the PurR repressor protein and two 16-bp palindromic operator sequences, one of which is located at the 59 end of the
mRNA transcript and the other of which is located 90 bp
upstream of the mRNA transcript (Fig. 1) (66). E. ictaluri does
not have a similar sequence at either of these locations, but it
does have a 16-bp sequence located approximately 50 bp up-

FIG. 1. Alignment of the E. ictaluri purA and E. coli purA promoter regions
(64). Shine-Dalgarno sequences, 210 and 235 regions, and start codons are
indicated for both E. ictaluri and E. coli by solid lines. Sixteen-base-pair palindromic purA operator sequences are indicated by dashed lines (66).

stream of the start of the purA mRNA transcript that aligns
well with the 16-bp consensus pur operator sequence in E. coli
(Fig. 1).
Construction of pEIl7. The strategy used to construct plasmid pEIl7 is shown in Fig. 2. First, a 3.5-kb NotI fragment of
the pEIl4 insert was subcloned into pBluescript to facilitate
mutagenesis of the E. ictaluri purA gene, and the resulting
6.5-kb plasmid was designated pEIl5. Next, the E. ictaluri purA
gene in pEIl5 was interrupted by deletion of a 598-bp NarI
fragment and insertion of the kanamycin resistance gene from
Tn903, obtained as a 1.7-kb BamHI fragment from plasmid
pNK2859 (25). The resulting 7.6-kb plasmid was designated
pEIl6. Finally, the 4.6-kb NotI pEIl6 insert was blunt end

FIG. 2. Plasmids involved in the construction of pEIl7, the plasmid used to
transfer a mutated copy of the purA gene into wild-type E. ictaluri by conjugation.
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ligated into the EcoRV site of the suicide plasmid pGP704
(35), and the resulting 8.5-kb plasmid carrying the DpurA::Kmr
construct and over 2,200 bp of flanking E. ictaluri chromosomal
sequence was designated pEIl7.
Construction and characterization of a purA mutant strain
of E. ictaluri. Transfer of pEIl7 into E. ictaluri by conjugation
with E. coli SM10 lpir as the donor strain was successful. In a
single conjugation, 1,865 kanamycin-resistant E. ictaluri colonies were isolated from approximately 9.8 3 106 E. ictaluri
CFU spread on selective media. Of 250 kanamycin-resistant
colonies screened, four ampicillin-sensitive colonies were identified, indicating the occurrence of a double-crossover recombination event and incorporation of the deletion-insertion mutation in the chromosome with concurrent loss of the suicide
plasmid. All four mutants failed to grow in EIMM alone but
grew in EIMM supplemented with 25 mg of adenine per ml.
Biochemically, the mutants maintained the wild-type phenotype, as determined with API 20E strips and sensitivity to
antibiotics other than kanamycin, and showed no evidence of
suicide plasmid persistence in plasmid preparations. Other
than adenine auxotrophy, the only apparent change was a
substantial reduction in colony size on BA, presumably due to
the low availability of adenine in mammalian blood, which
allows the mutants to be differentiated from wild-type strains.
One of the mutants, designated LSU-E2, was selected for
further characterization. Following 30 consecutive passages of
LSU-E2 in BHI, no revertants to the prototrophic phenotype
were detected after 7.5 3 1010 CFU from the final pass was
spread on EIMM, indicating the stability of the mutant phenotype.
The genotype of LSU-E2 was confirmed by PCR (Fig. 3).
Amplification of a portion of the Tn903 kanamycin resistance
gene with primers 903Kan1 and 903Kan2 yielded the predicted 624-bp band from mutant chromosomal DNA, indicating that the Tn903 gene had been incorporated into the
LSU-E2 chromosome. Only nonspecific bands were obtained
from wild-type E. ictaluri. Amplification with primers
pBRAmp1 and pBRAmp2 yielded only nonspecific bands
from both LSU-E2 and wild-type E. ictaluri, indicating that the
ampicillin resistance gene from pEIl7 had not been incorporated into the chromosome. Plasmid pEIl7 DNA that was used
as a positive control for this reaction yielded the predicted
709-bp band. Primers PurAU1 and 903Kan1 amplified the 39
end of the Tn903 insert and flanking purA gene sequence,
resulting in an 1,191-bp fragment from LSU-E2 DNA and no
amplification for wild-type DNA. Primers PurAM11 and
Tn903M2 yielded a 587-bp fragment from LSU-E2 DNA containing the 59 end of the Tn903 insert and flanking purA gene
sequence, and results were again negative for wild-type DNA.
Sequencing of the 1,191-bp PurAU1/903Kan1 fragment and
the 587-bp PurAM11/Tn903M2 fragment demonstrated purA
gene sequence up to the Tn903 ligation site, after which the
Tn903 gene sequence began for both fragments.
Attenuation trial. Except as noted below, dead fish in the
attenuation trial had external and internal lesions that were
consistent with ESC, and E. ictaluri was isolated from all suspected ESC-killed fish. All of the isolates from fish exposed to
LSU-E2 were positive for E. ictaluri on BHI plates, and no
revertants to wild-type phenotype were detected on BA.
Final percent mortalities in the attenuation trial indicate
that LSU-E2 is highly attenuated compared to the wild type by
all three routes of exposure (Table 3). LSU-E2 had a calculated LD50 of 5.1 3 107 CFU per fish for the injection route of
exposure, with mortality occurring only at the two highest
doses. An LD50 could not be calculated for the wild-type injection exposure because the lowest dose, of 130 CFU/fish,
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FIG. 3. Genotypic confirmation of the mutant LSU-E2 DpurA::Kmr construct by PCR. (A) Graphic representation of the PCR amplifications used; the
open bars above the LSU-E2 purA::Kmr construct represent the locations of the
PCR products shown in panel B. (B) Agarose gel showing the PCR products.
Lane 1 is a 1-kb ladder (Life Technologies, Gaithersburg, Md.). Lane 2 is the
1,104-bp PCR fragment amplified from wild-type E. ictaluri genomic DNA with
primers inside the purA gene. Lane 3 is the results of PCR amplification from
wild-type E. ictaluri genomic DNA with primers specific for the Tn903 kanamycin
resistance gene. Only nonspecific bands are present. Lane 4 is the 624-bp PCR
fragment amplified from mutant LSU-E2 genomic DNA with the same two
primers specific for Tn903 used in lane 3. Lanes 5 and 7 are the results of PCR
amplifications from wild-type genomic DNA with one primer specific for the
purA gene plus strand and one primer specific for Tn903. Only nonspecific bands
are present in both. Lane 6 is the 1,191-bp PCR fragment amplified from mutant
LSU-E2 genomic DNA with the same primers used in lane 5. Lane 8 is the
587-bp PCR fragment amplified from mutant LSU-E2 genomic DNA with the
same primers used in lane 7.

resulted in over 50% mortality. It can be concluded, however,
that the LD50 for the wild type is ,130 CFU/fish, which is more
than 5 logs10 lower than the LD50 for LSU-E2. The 1.3-3-105and 1.3-3-106-CFU/fish doses of injected wild type caused 96.7
and 100% mortality, respectively, compared to 0% mortality at
the equivalent doses for LSU-E2. No mortality was seen even
at the high doses for LSU-E2 in immersion and oral exposures
(Table 3). In contrast, 54.8% of fish exposed to wild-type E.
ictaluri died with the highest oral dose and 63.3% died in the
high-dose immersion exposure.
The kinetics of the injection exposure mortalities for wildtype and LSU-E2 E. ictaluri are shown in Fig. 4. In the highdose LSU-E2 injection exposure (1.6 3 108 CFU), all of the
deaths except for one occurred in the first 2 days following
exposure. At the next dose of LSU-E2 (1.6 3 107 CFU), half of
the deaths occurred in the first 2 days, and the other deaths
occurred from day 4 to day 17 postexposure. Five of the seven
deaths that occurred from days 4 to 17, however, had severe
external lesions characteristic of Cytophaga columnaris infection. In contrast, deaths in the wild-type exposures occurred
after a distinctive lag period that was more typical of a natural
E. ictaluri infection. The length of the lag effect was dose
dependent, as illustrated in Fig. 4. At the highest dose, deaths
began very rapidly, similar to the high-dose challenge with
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TABLE 3. Results of experimental infection of channel catfish
fingerlings with wild-type E. ictaluri and LSU-E2 by
three different routes of exposure
Treatment

Dose (CFUa)

% Mortality

Immersion
Wild type
Wild type
LSU-E2
LSU-E2
Control

6.5 3 106
6.5 3 107
1.6 3 106
1.6 3 107

16.7
63.3
0.0
0.0
0.0

Oral
Wild type
Wild type
LSU-E2
LSU-E2
Control

1.3 3 108
1.3 3 109
1.6 3 107
1.6 3 108

20.7
54.8
0.0
0.0
0.0

Injection
Wild type
Wild type
Wild type
Wild type
Wild type
LSU-E2
LSU-E2
LSU-E2
LSU-E2
Control

1.3 3 102
1.3 3 103
1.3 3 104
1.3 3 105
1.3 3 106
1.6 3 105
1.6 3 106
1.6 3 107
1.6 3 108

55.6
56.7
72.4
96.7
100.0
0.0
0.0
46.7
53.3
0.0

CFU/g of tissue by 2 h postexposure, and by 6 h postexposure,
numbers had increased to approximately 106 CFU/g (Fig. 6).
Numbers increased to approximately 107 per g from 3 to 5 days
postexposure, and all fish cultured positive for E. ictaluri at all
sampling times (Table 4). Bacterial counts in the liver did not
rise as quickly and were significantly lower than those in the
other tissues, similar to the results for LSU-E2.
Vaccine trial. Feeding activity remained normal following
immersion vaccination of channel catfish with LSU-E2 E. ictaluri, and there were no deaths. All fish that died following
subsequent immersion challenge with wild-type E. ictaluri cultured positive for E. ictaluri from the trunk kidney. Results of
the vaccine trial are presented in Table 5, and graphs of the
mortalities for both vaccinated and nonvaccinated fish are
shown in Fig. 6. Tanks containing nonvaccinated fish had a
final average mortality of 33.3%, which is significantly higher

For immersion route, doses are expressed as CFU per milliliter.

LSU-E2, but at the lower doses, almost all of the deaths occurred on day 6 or later.
Tissue distribution and persistence. All fish tested before
the experimental infections were negative for isolation of E.
ictaluri from any tissues. Adenine-auxotrophic E. ictaluri
LSU-E2 was isolated from at least one internal organ in all of
the immersion-exposed channel catfish samples from 2 to 48 h
postexposure, indicating that its invasive capabilities are intact
(Table 4). However, the infection was limited and no viable
LSU-E2 cells were detected in any organs at 72 h. At every
sampling time, bacterial concentrations in the tissues were
significantly higher for wild-type E. ictaluri than for LSU-E2
(Fig. 5).
Head and trunk kidneys had the highest numbers of bacteria
per gram of tissue, with about 104 CFU per g of tissue at 2 h
postexposure (Fig. 5). Liver and spleen contained about 3
logs10 fewer cells at 2 h. Numbers in the spleen continued to
increase up to 24 h postinfection, while numbers in the liver
remained low. Head and trunk kidney were also most likely to
carry LSU-E2, with only one fish negative for isolation at 48 h
(Table 4). In contrast, spleen was culture negative for at least
one fish at 2, 6, and 48 h, while liver was culture negative for at
least one fish at all times. In fact, the peak in average numbers
of bacteria per gram of spleen at 24 h postexposure (Fig. 5)
appears to result more from an increase in the number of fish
culturing positive from the spleen rather than an increase in
bacterial numbers in individual fish.
Similar to the attenuation trial, secondary bacterial infections were detected in some fish exposed to LSU-E2, except
that they were detected on days 2 and 3 postexposure. Although no pathology or clinical signs were grossly apparent,
three isolates of Pseudomonas sp. and one of Aeromonas hydrophila were identified.
In the wild-type exposure, there was approximately 104

FIG. 4. Percent mortalities that resulted from intraperitoneal injection of
wild-type E. ictaluri (A) and LSU-E2 (B) in channel catfish fingerlings at various
doses over time. Doses represent the number of bacteria (CFU) injected per fish.
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TABLE 4. Number of fish culturing positive from various tissues at different sampling times after immersion exposure
to wild-type and LSU-E2 E. ictaluria
Wild type

LSU-E2

Tissue

Spleen
Liver
Head kidney
Trunk kidney
Fishb
a
b

0h

2h

6h

12 h

24 h

2 days

3 days

4 days

0h

2h

6h

12 h

24 h

2 days

3 days

0
0
0
0
0

3
3
3
3
3

3
3
3
3
3

3
3
3
3
3

3
3
3
3
3

3
1
3
3
3

3
3
3
3
3

3
3
3
3
3

0
0
0
0
0

1
1
3
3
3

2
2
3
3
3

3
2
3
3
3

3
1
3
3
3

2
2
2
2
3

0
0
0
0
0

Out of three fish per sampling time.
Number of fish out of three that cultured positive from one or more tissues.

(P , 0.01) than the average mortality of 11.1% in the tanks
containing vaccinated fish. In fact, the average percent mortality in the tanks containing nonvaccinated fish was significantly higher (P , 0.01) than the average for the tanks con-

taining vaccinated fish on each day from day 7 postexposure to
the end of the study. The relative percent survival was 66.3
{relative percent survival 5 100 3 [1 2 (% mortality vaccinated/% mortality controls)]}.
The first deaths occurred in both nonvaccinated and vaccinated fish on day 6 post-immersion exposure to wild-type E.
ictaluri and steadily increased in nonvaccinated fish through
day 19 postexposure (Fig. 6). In vaccinated fish, however, additional deaths were delayed until after day 10 postexposure,
and almost all vaccinated fish deaths occurred between days 10
and 18 postexposure. As a result, the mean time of death for
vaccinated fish was 13.9 days, compared to only 11.5 days for
nonvaccinated fish.

The primary objective of this study was to develop a defined,
rationally attenuated mutant strain of E. ictaluri that would
remain invasive following immersion exposure for evaluation
as a live vaccine. As the first step in this process, the E. ictaluri
purA gene was successfully cloned and sequenced, resulting in
the first published report of gene structure and sequence data
for this important pathogen. Sequence results revealed that the
E. ictaluri purA gene has greater sequence identity with the E.
coli purA gene than with other known bacterial purA gene

FIG. 5. Concentrations of wild-type E. ictaluri (A) and LSU-E2 (B) in different internal organs of channel catfish at various sampling times following
immersion exposures. Numbers shown represent the averages of the log10 transformations of the number of bacteria per gram of tissue for the three tanks in
each treatment. Kid, kidney.

FIG. 6. Percent mortalities over time resulting from experimental E. ictaluri
infection by immersion exposure for nonvaccinated channel catfish and for channel catfish that were vaccinated with LSU-E2 by immersion.
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TABLE 5. Results from a single-dose LSU-E2 immersion vaccine
trial with wild-type E. ictaluri immersion challenge
Fish

Tank

Mortality
(no.)

Total no.
of fish

%
Mortality

Nonvaccinated

1
2
3
4
5
6

6
7
8
3
3
2

15
15
14
15
14
14

1
2
3
4
5
6

1
1
0
4
3
1

15
15
14
15
15
15

Vaccinated

Mean

SD

40.0
46.7
57.1
20.0
21.4
14.3

33.3

17.2

6.7
6.7
0.0
26.7
20.0
6.7

11.1

10.0

sequences (79.3%), which is expected because E. and E. ictaluri
are both members of the family Enterobacteriaceae, and E. coli
has greater overall identity with the E. ictaluri chromosome
than most species within this family (relative binding ratio of
31% at 60°C) (16). The degree of identity between E. coli and
E. ictaluri in the purA gene sequence is an indication that other
genes critical to survival are conserved between the two species.
In E. coli, B. subtilis, and Thiobacillus ferrooxidans, the purA
gene is under the control of its own promoter and is the only
gene on its mRNA transcript (26, 33, 64). The purA gene is
located at approximately min 95 on the E. coli chromosome,
and it is unlinked to the purB gene at min 25 and the other pur
genes involved in the synthesis of IMP from PRPP (5-phosphoa-D-ribosyl 1-pyrophate) (64). In fact, except for the purHD,
purMN, purEK, and guaBA operons, the purine biosynthetic
genes are all in monocistronic operons and dispersed on the E.
coli chromosome (66). The purA gene in E. ictaluri also appears to be in a monocistronic operon and has features in
common with the E. coli purA gene. The Shine-Dalgarno sequence and 210 and 235 regions are highly conserved between the species, and both have transcription terminators that
appear to be r independent. In addition, the presence of a
16-bp sequence upstream of the E. ictaluri purA gene that is
very similar to the 16-bp operator sequences upstream of the
E. coli purA genes suggests that E. ictaluri uses a similar regulatory mechanism to control purA expression.
The mating and transfer of pEIl7 from SM10 lpir E. coli into
E. ictaluri are the first report of a genetic transfer system for E.
ictaluri. The number of mutants obtained by transfer of pEIl7
into E. ictaluri (approximately 1 in .5,000 CFU screened)
indicates the presence of an efficient system for homologous
recombination in E. ictaluri. This conjugation system has also
proven useful for the generation of random transposon mutants in our laboratory with the pGP704-based pLOF vectors
(18).
The results of the experiments conducted to construct and
characterize E. ictaluri mutant strain LSU-E2 demonstrated
that the mutant meets several criteria important for a live
attenuated vaccine against ESC. First, LSU-E2 is very stable
and will not revert to the wild-type phenotype. Second, because
precise genetic methods were used to construct LSU-E2, only
the purA gene is mutated and genes that control pathogenesis
are intact. Consequently, LSU-E2 maintains the ability to invade and infect fish following immersion exposure. In addition,
all of the surface antigens of the virulent parent strain should
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be maintained in LSU-E2 for presentation to the host immune
system. Finally, the genetic defect causing the adenine-auxotrophic phenotype in LSU-E2 is well characterized, and isolates from fish can be easily distinguished from wild-type E.
ictaluri by growth in EIMM, by colony size on BA, or by PCR.
An effective live attenuated vaccine must also be safe. In the
attenuation trial, it was shown that LSU-E2 has an LD50 that
is greater than 5 log10 higher than the LD50 for wild-type E.
ictaluri for the injection route of exposure. This difference is
large enough to allow LSU-E2 to be used as a live vaccine, but
it is less than the difference in LD50 seen between adenineauxotrophic Salmonella typhimurium and wild-type S. typhimurium in mice. The LD50 for wild-type S. typhimurium ranged
from 14 to ,10 CFU by injection, while the LD50 for adenineauxotrophic strains ranged from 107 to 108.6 CFU (12, 42).
Attenuation of adenine auxotrophs in mammals is apparently
due to limited availability of adenine and adenosine in host
tissues (34). Although direct measurements of adenine availability in fish tissues are not available, fish differ from mammals
in certain aspects of purine metabolism, including the use of
adenine in uricolysis (17) and in the purine nucleotide cycle
(31), which produces ammonia for nitrogen excretion (38, 65).
These metabolic differences may result in increased adenine
availability in fish tissues compared to mammalian tissues and
account for the lower degree of attenuation for the purA auxotroph in catfish. The results of this study indicate that the
availability of adenine and adenosine in fish is limited, although possibly to a lesser extent than in mammals.
Mortality in the LSU-E2 injection treatments occurred only
at the two highest doses. At the highest injection dose of 1.6 3
108 CFU/fish, all of the deaths except for one occurred in the
first 2 days postexposure. Injection of LSU-E2 at 1.6 3 108
CFU per 5-g fish would result in a minimum of 3.2 3 107
CFU/g of tissue. This concentration is comparable to the concentrations of wild-type E. ictaluri seen in the internal organs
on the final day of the tissue distribution study reported here
(1 3 106 to 3.5 3 107 CFU/g of tissue), when the fish were
entering the final stage of infection. Similar results were reported for a purine-auxotrophic strain of Pseudomonas
pseudomallei that caused deaths in mice only within 2 days of
intraperitoneal injection, presumably as a result of the toxicity
of the bacterial suspensions (28). At the next highest injected
dose for LSU-E2 (approximately 1.6 3 107 CFU), half of the
deaths occurred in the first 2 days and half occurred between
days 4 and 17 postexposure. Most of the later dead fish had
severe external lesions characteristic of infection with C. columnaris, an opportunistic pathogen often associated with
stress in channel catfish (58). It appears that this dose of
LSU-E2 was stressful enough to predispose them to secondary
infection with C. columnaris. No morbidity, mortality, or external lesions were apparent at the two lower doses. This study
also demonstrated that LSU-E2 is attenuated compared to
wild-type E. ictaluri by immersion and oral routes of exposure,
because no morbidity or mortality occurred in fish exposed to
LSU-E2 by either route. Based on the numbers of LSU-E2
cells present in the tissues at 12 h, it is unlikely that LSU-E2 is
able to achieve numbers of bacteria in the tissues by the oral
and immersion routes that are equivalent to the numbers
achieved in the two high-dose injection exposures.
Only the immersion route of exposure was tested in the
tissue distribution and persistence study because of its importance as a potential route of vaccination for commercial producers. This study demonstrated that the adenine-auxotrophic
strain LSU-E2 has retained the ability to penetrate the host
and colonize internal organs, indicating that attenuation of this
strain in the immersion route of exposure is not due to its
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inability to invade the host. LSU-E2 was isolated from at least
one internal organ in all of the fish sampled from 2 to 48 h
postexposure (Table 4).
Although wild-type E. ictaluri achieved higher tissue concentrations than LSU-E2 in the internal organs following immersion exposure, the relative tissue distributions for wild type and
LSU-E2 were similar. Head and trunk kidneys were the most
consistently colonized and had the highest tissue concentrations for both (Fig. 5). Wild-type concentrations were approximately 2 logs10 higher than LSU-E2 in these organs until 24 h
postinfection, when wild-type numbers began to increase,
while mutant numbers began to decrease. The spleen had the
next highest concentrations of wild type and LSU-E2, followed
by the liver.
Baldwin and Newton (4) also saw higher concentrations of
E. ictaluri in the trunk kidney than the liver following experimental infection of channel catfish fingerlings by oral exposure.
By 96 h postinfection, bacterial concentrations in the liver and
trunk kidney were similar in both studies (approximately 106
CFU/g of tissue in the liver and 107 CFU/g of tissue in the
trunk kidney). By contrast, Nusbaum and Morrison (41) reported that counts of radiolabeled E. ictaluri cells were positive
earlier, persisted longer, and were higher in the liver than in
the trunk kidney following immersion exposure. The different
tissue distribution reported by Nusbaum and Morrison may
have resulted from an altered disease pathogenesis due to the
low temperature at which the experiment was conducted
(20°C), or it may reflect the detection of nonviable E. ictaluri
antigens accumulated in the liver.
The purA mutant strain of E. ictaluri reported in this study
was able to invade channel catfish by immersion exposure
much more efficiently than a Salmonella dublin purA mutant
was able to invade mice by oral exposure (54). Only one mouse
cultured positive on day 1 postexposure, based on examination
of the internal organs of mice exposed to the S. dublin mutant,
and none were positive after that. However, S. typhimurium
purA mutant strains injected intravenously in mice persisted at
a level of about 104 CFU per organ in the liver and spleen until
day 21 postexposure, after which they gradually cleared (42).
Liver and spleen cultures were still positive for the mutant at
49 days postexposure. One possible explanation for the relatively brief persistence of the E. ictaluri purA mutant in channel
catfish compared to the S. typhimurium purA mutant in mice is
that different routes of exposure were used in the two studies.
However, LSU-E2 concentrations in the head and trunk kidneys at 24 h following immersion exposure (approximately 104
CFU/g of tissue) were equivalent to concentrations of the S.
typhimurium purA mutants in the liver and spleen at 24 h
following injection exposure, indicating that the lack of
LSU-E2 persistence is not due to a failure to achieve sufficient
tissue concentrations. A more likely possibility is that the E.
ictaluri purA mutant is more easily killed by macrophages than
is the wild type, similar to guanine auxotrophs of Yersinia pestis
and purine auxotrophs of S. typhimurium (11, 57), and is consequently cleared from the tissues quickly. Several investigators have suggested that E. ictaluri is capable of intracellular
survival and replication in catfish macrophages (4, 37, 39),
while others have reported an apparent inability to invade
nonphagocytic cells (4, 24). S. typhimurium, on the other hand,
is capable of penetration, survival, and replication inside diverse eukaryotic cell types, including epithelial and phagocytic
cells (27). The extended persistence of the S. typhimurium purA
mutant compared to the E. ictaluri purA mutant may be due to
its ability to survive in cell types other than macrophages.
The results of the vaccine trial indicate that immersion vaccination of E. ictaluri-free channel catfish with a purA mutant
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strain of E. ictaluri provides significant protection against experimental infection with wild-type E. ictaluri. This is in contrast to results reported with other species. An S. typhimurium
purA mutant was protective in mice following intraperitoneal
injection of 2.5 3 105 or greater CFU but not at a dose of 2.5 3
103 CFU (34). In a subsequent study, an S. typhimurium purA
mutant provided only minimal protection in mice following
intravenous injection and failed to protect following oral vaccination (34). It was not determined, however, whether the
failure to protect was due to a failure to invade or to a failure
to induce protective immunity. Sigwart et al. (54), however,
indicated that only one of three mice was culture positive for a
purA mutant of S. dublin at day 1 postexposure and that all
mice were culture negative on subsequent sampling days. They
further reported that the purA mutant induced significantly less
serum and mucosal antibody compared to an aroA mutant.
Our study indicates that the E. ictaluri purA mutant retains its
ability to invade from the water, persists in the host for at least
48 h, and provides significant protection of channel catfish
from ESC by immersion vaccination under controlled laboratory conditions with E. ictaluri-free channel catfish. Because
immersion vaccination is a practical method of vaccinating
channel catfish fry and fingerlings, our adenine-auxotrophic
LSU-E2 has potential as a live vaccine for use by commercial
catfish producers.
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